Vireo Q2 FY26 adjusted EBITDA climbs 212% to US $41.5 million; GAAP revenue rises 335.1% to US $209.3 million

• Vireo Growth Q2 2026 GAAP revenue rose to USD 209.3 million from a year earlier, driven by recently closed M&A transactions.
• GAAP gross profit climbed to USD 95.3 million, lifting gross margin to 45.5% from 42.4% a year earlier.
• Net results swung to a GAAP loss of USD 0.1 million; GAAP operating loss widened to USD 6.3 million.
• Adjusted EBITDA (non-GAAP) increased to USD 41.5 million; margin narrowed to 19.8% from 27.7% a year earlier.
• Closed Hawthorne, Eaze, Bridgewell in Q2; later closed PharmaCann, announced Cannabist asset deal, Planet 13 merger, Ohio entry; cash USD 122.7 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vireo Growth Inc. published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.